DILI, 9 September 2020 (TATOLI) – The Health Ministers from Member countries of the WHO South East Asia Region will participate in 73rd Regional Committee Session of WHO South-East Asia on 9 – 10 September to discuss measures to curtail the outbreak amidst the COVID-19.
The Session will be Hosted by Thailand which is being held virtually in view of the COVID-19 pandemic.
WHO Director General, Dr Tedros Adhanom, Regional Director for WHO South-East Asia, Dr Poonam Khetrapal Singh, Health Ministers and senior health officials of the 11 Member countries of the Region, UN Agencies, partners, donors and civil society representatives would be among those attending the two-day session.
The pandemic has severely strained health systems across the Region. The countries will share the experiences and lesson learnt about maintaining the essential health services and accelerating resumption of disrupted health care services, which has been advocating by the WHO as part of the COVID-19 response.
The team meeting will also review about progress, challenges, capacities and opportunities for the decade of health workforce strengthening 2015-2024.
The annual report on monitoring progress on universal health coverage and health related Sustainable Development Goals, are also among the agenda of the session from the mid-term.
Further discussion will be on the progress of implementation of some previous resolution implementing by the Regional Committee such as promoting physical activity, the regional action plan to reduce harmful use of alcohol, access to medicines, dengue control and malaria elimination and measles and rubella elimination.
The regional has eight flagship priorities programme, these programme were to eliminate measles and rubella by 2023, prevent and control noncommunicable diseases through multisectoral policies and plans, with a focus on “best buys”; accelerate reduction of maternal, neonatal and under five mortality; continue progressing towards universal health coverage with a focus on human resources for health and essential medicines; further strengthen national capacity for preventing and combating antimicrobial resistance; scale-up capacity development in emergency risk management in countries; finish the task of eliminating neglected tropical diseases (NTDs) and other diseases on the verge of elimination; accelerate efforts to end TB by 2030.
Over these programme, the Region has been making remarkable progress around the flagships and beyond.
During the Session some countries will be felicitated for the recent public health achievements.
TATOLI
